FemHealth Ventures is a women’s health-focused venture capital firm based in the United States. Founded to address long-standing gaps in healthcare innovation, the firm invests exclusively in companies improving health outcomes for women. FemHealth Ventures is known for its research-driven approach and for helping define women’s health as a distinct, investable category within venture capital.
FemHealth Ventures invests across the full spectrum of women’s health, including drugs, medical devices, diagnostics, and digital and AI-enabled healthcare technologies.
The firm targets companies addressing unmet needs in conditions that appear only in women, mostly in women, or differently in women, a framework the firm formally introduced and continues to champion across the industry.
FemHealth Ventures closed its second fund, FemHealth Ventures Fund II, at $65 million in December 2025.
The fund was backed by a mix of returning limited partners and new institutional investors, bringing the firm’s total assets under management to approximately $100 million across two funds. Fund II builds on the performance of Fund I, which launched in 2021 and has been recognized as a top-decile performer across both DPI and IRR by leading venture benchmarks.
The new fund will continue backing early-stage and growth-stage companies developing therapies, devices, diagnostics, and digital platforms focused on women’s health, with capital allocated to support follow-on investments as portfolio companies scale.
Leadership
FemHealth Ventures is led by Maneesha Ghiya, managing partner and a leading voice in the women’s health investment space. The team also includes venture partner Sara Crown Star, who supports sourcing, diligence, and portfolio development.
Investment Strategy
The firm’s strategy is grounded in category creation and scientific rigor. FemHealth Ventures applies its proprietary FemHealth Framework to evaluate opportunities, ensuring investments are aligned with real clinical and market gaps in women’s health. The firm invests with a long-term mindset, supporting companies from early clinical or product stages through commercialization and scale, while maintaining close relationships with founders and operators.
Notable Investments
FemHealth Ventures has backed a range of companies across therapeutics, medical devices, diagnostics, and digital health platforms focused on women’s health. The portfolio reflects a balance of clinical innovation and technology-enabled healthcare, with an emphasis on solutions that can achieve both medical impact and strong commercial adoption.
Notable Exits
FemHealth Ventures has not publicly disclosed exits to date, though early fund performance metrics place its first fund among top-decile venture funds.
Other
FemHealth Ventures is deeply thesis-driven and expects strong clinical, regulatory, and market understanding from teams. The firm is particularly well suited for founders building category-defining women’s health companies and offers credibility, domain expertise, and long-term support in a sector that has historically been underfunded.
United States
